The Medicine Maker: The Biosimulation Generation
The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…
Danielle PillsburyJuly 1, 2025
Bioequivalence study of two formulations of lurasidone film coated tablets in healthy subjects under fed conditions
Learn how fed‑condition crossover study confirms lurasidone bioequivalence and comparable safety using Phoenix WinNonlin.
CertaraJuly 1, 2025
Impact of body weight on mycophenolic acid population pharmacokinetics in paediatric lupus nephritis: a pharmacogenomic integration study
Find out how PopPK modelling shows body weight is the key driver of MPA exposure…
CertaraJuly 1, 2025
5 clinical development challenges model-based meta-analysis (MBMA) helps address
June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…
CertaraJune 30, 2025
Maintain & adapt pharma market access digital tools using feedback
Maintain the credibility of your pharma market access digital tools through continuous updates based on…
CertaraJune 30, 2025
The do’s and don’ts of define.xml
Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with…
CertaraJune 27, 2025
Introducing the project progress report – How to identify bottlenecks with Design Hub
Learn how to identify bottlenecks in your research process by utilizing the new project progress…
Jan ChristophersonJune 27, 2025
How Model-informed drug development rescue projects from a risky situation
Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…
CertaraJune 26, 2025
NMR predictor guide: Which type is best for you?
Find out which type of NMR predictor may best serve your needs from this guide…
CertaraJune 26, 2025
